Clinical application of Clostridium botulinum type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity
Clinical application of Clostridium botulinum type A neurotoxin purified by a simple procedure for patients with urinary incontinence caused by refractory destrusor overactivity
复制标题
DOI:
10.1111/j.1574-695x.2007.00301.x
复制
发表时间:
2007-10-01
影响因子:
--
通讯作者:
Oguma, Keiji
中科院分区:
文献类型:
--
作者:
Lee, Jae-Chul;Yokoyama, Teruhiko;Oguma, Keiji
Type A neurotoxin of Clostridium botulinum was purified by a simple procedure using a lactose gel column. This procedure was previously reported for type B neurotoxin. Hemagglutinin-positive toxins (19S and 16S) were bound to the column under acid conditions, and the neurotoxin alone was dissociated from these hemagglutinin-positive toxins by changing the pH of the column to an alkaline condition. The toxicity of this purified toxin preparation was retained for at least 1 year at -30 degrees C by supplementing it with either 0.1% albumin or 0.05% albumin plus 1% trehalose. This preparation was used to treat 18 patients with urinary incontinence caused by refractory idiopathic and neurogenic detrusor overactivity; 16 of the patients showed excellent improvement. Improvements started within 1 week after injection in most cases and lasted 3-12 months. 12S toxin dissociates into an NTX and an NTNH. Recently, we discovered that 19S toxin is a dimer of 16S toxin, and that haemagglutinin consists of four subcomponents designated AA-1, AA-2, AA-3a and HA-3b.